Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCAX | IOVA | CTMX | ||
| Company | Bicara Therapeutics Inc | Iovance Biotherapeutics Inc | Cytomx Thera | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.29 | 2.26 | 5.46 | ||
| High | 17.09 | 2.32 | 5.61 | ||
| Low | 15.73 | 2.24 | 5.10 | ||
| Latest | 17.02 | 2.31 | 5.38 | ||
| Change | +0.27 | -0.05 | -0.01 | ||
| % Change | +1.61% | -2.12% | -0.19% | ||
| Volume | 196,056 | 3,099,332 | 1,495,825 | ||
| 20-Day Average Volume | 539,343 | 12,156,333 | 3,038,386 | ||
| Previous Close | 16.75 | 2.36 | 5.39 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 17.04 | 2.57 | 4.35 | ||
| 20-Day Raw Stochastic | 46.14% | 9.62% | 89.25% | ||
| 20-Day Relative Strength | 49.37 | 45.82 | 70.66 | ||
| Weighted Alpha | +47.79 | -36.44 | +229.47 | ||
| Today's Opinion | 40% Buy | Hold | 100% Buy | ||
| Previous Opinion | 56% Buy | 32% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 24% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.73% since 01/12/26 | -4.79% since 01/12/26 | +26.84% since 01/12/26 | ||
| Low | 15.77 on 01/20/26 | 2.21 on 01/15/26 | 4.09 on 01/13/26 | ||
| High | 18.05 on 01/15/26 | 2.42 on 01/13/26 | 5.70 on 01/16/26 | ||
| 1-Month | |||||
| %Chg | -3.66% since 12/19/25 | -7.86% since 12/19/25 | +37.63% since 12/19/25 | ||
| Low | 15.64 on 01/05/26 | 2.21 on 01/15/26 | 3.89 on 12/22/25 | ||
| High | 18.49 on 12/23/25 | 2.99 on 12/26/25 | 5.70 on 01/16/26 | ||
| 3-Month | |||||
| %Chg | +4.27% since 10/20/25 | -1.51% since 10/20/25 | +47.19% since 10/20/25 | ||
| Low | 13.70 on 11/11/25 | 1.76 on 11/05/25 | 3.21 on 10/23/25 | ||
| High | 19.68 on 12/11/25 | 2.99 on 12/26/25 | 5.70 on 01/16/26 | ||
| 6-Month | |||||
| %Chg | +55.12% since 07/18/25 | +2.47% since 07/18/25 | +130.82% since 07/18/25 | ||
| Low | 9.57 on 08/11/25 | 1.76 on 11/05/25 | 1.72 on 08/14/25 | ||
| High | 19.71 on 10/13/25 | 4.33 on 07/23/25 | 5.70 on 01/16/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 917,599 | 936,844 | 913,255 | ||
| Shares Outstanding, K | 54,782 | 396,968 | 169,435 | ||
| Annual Sales | 0 | 164,070,000 | 138,100,000 | ||
| Annual Net Income | -68,000,000 | -372,180,000 | 31,870,000 | ||
| Last Quarter Sales | 0 | 67,460,000 | 5,960,000 | ||
| Last Quarter Net Income | -36,330,000 | -91,250,000 | -14,230,000 | ||
| 60-Month Beta | -0.79 | 0.77 | 2.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.67 on 11/10/25 | -0.25 on 11/06/25 | -0.09 on 11/06/25 | ||
| Latest Earnings Date | 03/26/26 | 02/26/26 | 03/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 10.63 | ||